Canada Life’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-5,804
Closed -$511K 2527
2015
Q2
$511K Buy
5,804
+5,580
+2,491% +$512K ﹤0.01% 1001
2015
Q1
$20K Hold
224
﹤0.01% 2339
2014
Q4
$19K Hold
224
﹤0.01% 2345
2014
Q3
$17K Sell
224
-5,580
-96% -$451K ﹤0.01% 2335
2014
Q2
$469K Hold
5,804
﹤0.01% 922
2014
Q1
$439K Hold
5,804
﹤0.01% 918
2013
Q4
$419K Hold
5,804
﹤0.01% 921
2013
Q3
$398K Buy
5,804
+224
+4% +$14.8K ﹤0.01% 855
2013
Q2
$354K Buy
+5,580
New +$363K ﹤0.01% 552

Other funds holding NVS

Canada Life's NVS Position: Q3 2015 in Review

Canada Life sold out of Novartis (NVS) in Q3 2015, closing a stake of 5,804 shares — an estimated $511K sold.

Canada Life first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $511K in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

  • Canada Life reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
  • Canada Life sold 5,804 Novartis shares in Q3 2015, an estimated $511K.
  • Canada Life first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
  • Canada Life's Novartis position peaked at $511K in Q2 2015.
  • 926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Canada Life's 13F filing for Q3 2015, filed 10 Nov 2015.